Amgen, Inc.(NASDAQ:AMGN) will present at the Goldman Sachs Global Healthcare Conference at 1:20 p.m. PT on Wednesday, June 11, 2014, at the Terranea Resort in Rancho Palos Verdes, Calif. Anthony C. Hooper, executive vice president of Global Commercial Operations at Amgen, will present at the conference. Amgen, Inc.(NASDAQ:AMGN) net profit margin is 24.90% and weekly performance is 1.58% On last trading day company shares ended up $117.82 .Analysts mean target price for the company is $132.78 Amgen, Inc.(NASDAQ:AMGN) distance from 50-day simple moving average (SMA50) is 2.34%.
Boston Scientific Corporation(NYSE:BSX) has launched the RESPOND Post Market Registry to evaluate the real world performance of the Lotus Valve System – a differentiated second generation transcatheter aortic valve implantation (:TAVI) technology. Boston Scientific Corporation (NYSE:BSX) shares fell -0.38% in last trading session and ended the day on $13.13. BSX Gross Margin is 70.20% and its return on assets is 2.20% .Boston Scientific Corporation (NYSE:BSX) quarterly performance is -4.16%.
Cellectis (Paris:ALCLS) (Alternext: ALCLS.PA), a leader of engineered CART cell therapies, and Thermo Fisher Scientific Inc. (NYSE:TMO) announced that they have entered into a series of agreements covering the uses of TAL nucleases under the brand name TALEN™. Thermo Fisher Scientific Inc. (NYSE:TMO) shares moved up 0.68% in last trading session and was closed at $119.81, while trading in range of119.17 – $120.05. Thermo Fisher Scientific Inc.(NYSE:TMO) year to date (YTD) performance is 7.72%.
On June 4, The HealthCare segment at Bayer AG (ADR) (OTCMKTS:BAYRY) announced the initiation of a new study on its pulmonary hypertension drug, Adempas (riociguat). The company initiated a phase IIb RISE-IIP (Riociguat in Patients with Symptomatic Pulmonary HypErtension associated with Idiopathic Interstitial Pneumonias) study (n=120) on Adempas, which will be evaluating the efficacy and safety of the drug in patients suffering from symptomatic PH associated with idiopathic interstitial pneumonia (:IIP). Bayer AG (ADR) (OTCMKTS:BAYRY) shares closed at $143.51 in last trading session, while 52 week range of 101.94 – $145.20.
Siemens AG (ADR) (OTCMKTS:SIEGY) ‘s stock had its “buy” rating reiterated by stock analysts at Investec in a report issued on Wednesday. They currently have a GBX 1,450 ($24.31) price objective on the stock. Siemens AG (ADR) (OTCMKTS:SIEGY) shares closed at $135.34in last trading session, while 52 week range of 99.07 – $139.28.
Leave a Reply